Mepivacaine B. Braun

Mepivacaine, the active ingredient in Mepivacaine B. Braun, is a local anesthetic presented as a sterile solution for epidural, intramuscular and perineural use. It provides rapid onset nerve block for surgical and diagnostic procedures in adult patients. GNH USA supplies Mepivacaine B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mepivacaine is a local anesthetic used in procedures that require temporary loss of sensation. - Local anesthesia: produces rapid, short‑duration numbness for minor surgical or dental procedures. - Epidural analgesia: enables pain control during labor, obstetric surgery, or postoperative recovery. - Peripheral nerve block: facilitates anesthesia of a specific limb or region for orthopedic or vascular surgery. - Intramuscular injection: provides localized anesthesia for muscle biopsies or minor interventions. - Dental procedures: allows painless tooth extractions and restorative work.

Mepivacaine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Nausea - Tingling or numbness around the injection site - Metallic taste in the mouth - Transient hypotension - Injection site pain

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Cardiac arrhythmias, including ventricular tachycardia - Central nervous system toxicity such as seizures - Methemoglobinemia (rare)

When using Mepivacaine, clinicians should observe several safety measures. - Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiovascular monitoring: observe for arrhythmias in patients with heart disease. - Dosage caution: avoid excessive volumes that may increase systemic toxicity. - Pregnancy consideration: use only if the anticipated benefit justifies potential risk. - Elderly patients: consider dose reduction due to decreased metabolic clearance. - Store at below 25°C: keep in the original container, protect from light and moisture.

Mepivacaine can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may potentiate cardiotoxicity. - Beta‑blockers: increase risk of bradycardia and hypotension. - MAO inhibitors: may enhance central nervous system toxicity.

Moderate Interactions (Monitor Closely): - Other local anesthetics: cumulative toxicity risk. - CNS depressants (e.g., benzodiazepines, opioids): may augment sedation and respiratory depression. - Diuretics: may alter plasma protein binding and affect drug levels.